Skip to main content
. Author manuscript; available in PMC: 2025 Mar 1.
Published in final edited form as: Pediatr Infect Dis J. 2023 Nov 22;43(3):250–256. doi: 10.1097/INF.0000000000004190

Table 2a.

Mtb infection incidence rates comparison between children with and without HIV exposure

N n (%) Rate per 100 PY (95% CI) HR* (95% CI) p

12 month incidence 298 17 (5.7) 5.8 (3.6–9.4)
HIV Exposure 165 13 (7.9) 8.1 (4.7–14.0) 2.70 (0.87–8.21) 0.085
No HIV exposure 133 4 (3.0) 3.0 (1.1–8.1) ref --

12–24 month incidence 265 5 (1.9) 2.0 (0.8–4.8)
HIV Exposure 141 4 (2.8) 3.1 (1.1–8.2) 3.58 (0.40–32.1) 0.254
No HIV exposure 124 1 (0.8) 0.8 (0.1–5.9) ref --

Cumulative 24-months incidence 322 22 (6.8) 3.6 (2.4–5.5)
HIV Exposure 170 17 (10.0) 5.4 (3.4–8.7) 3.10 (1.16–8.54) 0.024
No HIV exposure 152 5 (3.3) 1.7 (0.7–4.1) ref --

n/N

*

Hazard ratio (HR) estimated using Cox proportional hazards regression

Includes 2 children with new HIV diagnosis at 6 weeks and 6 months of age